Long-term result of endoscopic Histoacryl&reg; (N-butyl-2-cyanoacrylate) injection for treatment of gastric varices

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

468

HTML

5428

Figures (1-6)

250

Tables (1-6)

234

Sum=6380

Mar 21, 2011 (publication date) through Feb 7, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Mar 21, 2011; 17(11): 1494-1500
Published online Mar 21, 2011. doi: 10.3748/wjg.v17.i11.1494

Table 2 Baseline Characteristics-27 patients who underwent primary prophylaxis

Clinical characteristics	Number	%
No. of patients (male/female)	27(21/6)	71.4/28.6
Mean age (yr)	55.29
Etiology of gastric varices
Liver cirrhosis	27	100
Hepatitis B	14	51.9
Hepatitis C	3	11.1
Alcoholic	6	22.2
Unknown	4	14.8
Association of hepatocellular carcinoma	5	18.5
Child-Pugh classification (A/B/C)	12/11/4	44.4/40.7/14.9
Sarin classification of gastro-esophageal varices
GOV1	15	55.6
GOV2	10	37
IGV1	2	7.4
IGV2	0	0
Form of gastric varices
F1	3	11.1
F2	9	33.3
F3	15	55.6

GOV: Gastro-esophageal varices; IGV: Isolated gastric varices.

Citation: Kang EJ, Jeong SW, Jang JY, Cho JY, Lee SH, Kim HG, Kim SG, Kim YS, Cheon YK, Cho YD, Kim HS, Kim BS. Long-term result of endoscopic Histoacryl^® (N-butyl-2-cyanoacrylate) injection for treatment of gastric varices. World J Gastroenterol 2011; 17(11): 1494-1500
URL: https://www.wjgnet.com/1007-9327/full/v17/i11/1494.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i11.1494